Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as $138.44 and last traded at $143.25, with a volume of 277 shares traded. The stock had previously closed at $143.70.
Merck KGaA Price Performance
The stock’s 50 day simple moving average is $147.55 and its 200-day simple moving average is $164.48. The firm has a market cap of $17.94 billion, a price-to-earnings ratio of 21.20 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Transportation Stocks Investing
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What Are Earnings Reports?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Stocks to Consider Buying in October
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
